Effects of apoA-II, C-I, C-II on in vivo metabolism of apoB-containing lipoproteins-stable, isotope study

apoA-II、C-I、C-II 对含 apoB 脂蛋白体内代谢的影响-稳定同位素研究

基本信息

  • 批准号:
    14571110
  • 负责人:
  • 金额:
    $ 1.73万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

In addition to an elevated LDL-cholesterol (C), an increased triglyceride (TG) rich lipoprotein has drawn more attention as the risk for coronary artery disease. TG-rich lipoproteins (TRL) comprise heterogeneous lipoproteins subclasses, depending upon apoprotein composition. Among them, apoC-III and apoE have been extensively investigated, whereas effects of other apoptoteins such as apoA-II, C-I, C-II are largely unknown. In the present study, we wish to investigate 1) distribution of VLDL subcleasses which differ in apolipoprotein compositions, 2) in vivo role of apoC-III and apoE by utilyzing stable isotopically labeled amino acid tracer study. ApoA-II, C-I, and C-II containing VLDL comprise 13%, 17%, and 16% of VLDL, respectively, representing minor fractions among TRL relative to those containing either apoC-III or apoE. Those containing the apolipoproteins comprise more cholesterol and TG per particle and tend to have other apoproteins. Distribution does not change postprandially, but absolute concentrations increase by fat ingestion. In vivo kinetic study revealed that E-/C-and E-/C+ VLDL are catabolized faster than E+/C-and E+/C+ particles. This was true for IDL and LDL, too. ApoE containing particle, especially E+/C-, are preferentially catabolized by direct removal via LDL receptor or/and LRP with a delayed lipolysis. To the contrary, E-/C-and E-/C+ particles are catablized in favor of lipolysis rather than direct removal. In conclusions, these results demonstrated 1) that, unlike apoC-III and apoE, TRL containing apoA-II, apoC-I, or apoC-II represent minor fraction, thus not suitable for kinetic study. Combination of stable isotope tracer study with immunoaffinity isolation technique provides for the first time a new insight into the role of apoC-III and apoE on TRL, namely inhibitory effect of lipolysis and promoting direct uptake by apoE and promoting lipolysis by apoC-III.
除了低密度脂蛋白胆固醇(C)升高外,富含甘油三酯(TG)的脂蛋白作为冠状动脉疾病的风险引起了更多的关注。富含甘油三酯的脂蛋白(TRL)包括不同的脂蛋白亚类,这取决于载脂蛋白的组成。其中,apoC-III和apoE已被广泛研究,而其他凋亡素如apoA-II、C-I、C-II的作用尚不清楚。在本研究中,我们希望通过稳定的同位素标记氨基酸示踪剂研究1)载脂蛋白组成不同的VLDL亚链的分布,2)载脂蛋白C-III和载脂蛋白E在体内的作用。含有极低密度脂蛋白的载脂蛋白A-II、C-I和C-II分别占极低密度脂蛋白的13%、17%和16%,相对于含有载脂蛋白C-III或载脂蛋白E的载脂蛋白,TRL的比例很小。那些含有载脂蛋白的人每颗粒含有更多的胆固醇和甘油三酯,并倾向于含有其他载脂蛋白。餐后分布不会改变,但绝对浓度会因脂肪摄取而增加。体内动力学研究表明,E-/C-和E-/C+VLDL的降解速度快于E+/C-和E+/C+粒子。IDL和低密度脂蛋白也是如此。含有APOE的颗粒,尤其是E+/C-,优先通过低密度脂蛋白受体或/和LRP直接清除,然后延迟脂解。相反,E-/C-和E-/C+颗粒被催化,有利于脂肪分解,而不是直接去除。综上所述,这些结果表明:1)与apoC-III和apoE不同,含有apoA-II、apoC-I或apoC-II的TRL所占比例较小,因此不适合进行动力学研究。结合稳定同位素示踪研究和免疫亲和分离技术,首次对apoC-III和apoE在TRL中的作用提供了新的认识,即抑制脂解作用和促进apoE直接摄取和促进apoC-III的脂解作用。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Keio Okubo: "Abnormal high density lipoprotein apoliprotein A-I and A-Il kinetics in hemodialysis patients -a stable isotope study."American Journal of Society of Nephrology. (in press).
Keio Okubo:“血液透析患者中​​异常的高密度脂蛋白载脂蛋白 A-I 和 A-II 动力学 - 一项稳定同位素研究。”美国肾脏病学会杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Katsunori Ikewaki: "Effect of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia-a nuclear magnetic resonance study"International Journal of Cardiology. (in press).
Katsunori Ikewaki:“苯扎贝特对高甘油三酯血症患者脂蛋白亚类和炎症标志物的影响——一项核磁共振研究”《国际心脏病学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Keio Okubo: "Abnormal high density lipoprotein apoliprotein A-I and A-II kinetics in hemodialysis patients - a stable isotope study."American Journal of Society of Nephrology. (in press). (2004)
Keio Okubo:“血液透析患者的异常高密度脂蛋白载脂蛋白 A-I 和 A-II 动力学 - 一项稳定同位素研究。”美国肾脏病学会杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Katsunori Ikewaki: "Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia - a nuclear magnetic resonance study"International Journal of Cardiology. (in press). (2004)
Katsunori Ikewaki:“苯扎贝特对高甘油三酯血症患者脂蛋白亚类和炎症标志物的影响 - 核磁共振研究”国际心脏病学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Katsunori Ikewaki: "Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertrigly-ceridemia-a nuclear magnetic resonance study."International Journal of Cardiology. (in press).
Katsunori Ikewaki:“苯扎贝特对高甘油三酯血症患者脂蛋白亚类和炎症标志物的影响 - 一项核磁共振研究。”国际心脏病学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IKEWAKI Katsunori其他文献

IKEWAKI Katsunori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IKEWAKI Katsunori', 18)}}的其他基金

Effects of statin on apolipoprotein metabolism in patients with hemodialysis
他汀类药物对血液透析患者载脂蛋白代谢的影响
  • 批准号:
    22591002
  • 财政年份:
    2010
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inter-relationship between lipoprotein and glucose metabolism-analysis using stable isotope study
脂蛋白和葡萄糖代谢之间的相互关系——使用稳定同位素研究进行分析
  • 批准号:
    17590949
  • 财政年份:
    2005
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
In vivo evidence of a delayed catabolism of remnant and decreased production of apoA-I in patients with chronic renal failure. -A stable isotope study.
慢性肾功能衰竭患者残余物分解代谢延迟和 apoA-I 产生减少的体内证据。
  • 批准号:
    11671054
  • 财政年份:
    1999
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
用于转移性结直肠癌化疗免疫治疗的肿瘤靶向多模态纳米配位聚合物
  • 批准号:
    10639649
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
使用经过训练的免疫抑制纳米生物制剂来实现非人类灵长类动物同种异体心脏移植的耐受性
  • 批准号:
    10642598
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Chromogranin A is an aging risk factor
嗜铬粒蛋白 A 是衰老的危险因素
  • 批准号:
    10667265
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
  • 批准号:
    10629550
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
The Role of Lipids in Alzheimer's Disease and Related Dementias among Black Americans: Examining Lifecouse Mechanisms
脂质在美国黑人阿尔茨海默病和相关痴呆中的作用:检查生命机制
  • 批准号:
    10643344
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
  • 批准号:
    10603408
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
  • 批准号:
    10733720
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
  • 批准号:
    10722515
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in a Community-based Weight Loss Intervention Program
接触全氟烷基物质对减肥的影响:对参加社区减肥干预计划的超重/肥胖西班牙裔儿童的初步研究
  • 批准号:
    10724050
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了